| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS30036302 | HIV | ENSG00000100479.14 | protein_coding | POLE2 | No | No | 5427 | P56282 |
| TVIS20051743 | HPV | ENSG00000100479.14 | protein_coding | POLE2 | No | No | 5427 | P56282 |
| TVIS44010997 | HTLV-1 | ENSG00000100479.14 | protein_coding | POLE2 | No | No | 5427 | P56282 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | POLE2 |
|---|---|
| DrugBank ID | DB00242 |
| Drug Name | Cladribine |
| Target ID | BE0003615 |
| UniProt ID | P56282 |
| Regulation Type | inhibitor |
| PubMed IDs | 19576186 |
| Citations | Zhenchuk A, Lotfi K, Juliusson G, Albertioni F: Mechanisms of anti-cancer action and pharmacology of clofarabine. Biochem Pharmacol. 2009 Dec 1;78(11):1351-9. doi: 10.1016/j.bcp.2009.06.094. Epub 2009 Jul 1. |
| Groups | Approved; Investigational |
| Direct Classification | Purine 2'-deoxyribonucleosides |
| SMILES | NC1=C2N=CN([C@H]3C[C@H](O)[C@@H](CO)O3)C2=NC(Cl)=N1 |
| Pathways | |
| PharmGKB | PA449027 |
| ChEMBL | CHEMBL1619 |
